CMRX Wutah pendapatan triwulanan Chimerix, Inc.

Simbol lan logo merek Chimerix Inc (CMRX)

Investing in Chimerix, Inc. (CMRX) involves uncertainties regarding drug approvals and volatility in clinical data. The GURU.Markets platform transmits the quarterly revenue growth rate, where 1326.40 captures the value of this parameter. Government biodefense contracts and an approved drug portfolio ensure business stability. Efficiency is enhanced through the implementation of robotic molecule screening and the automation of research data processing.

Chimerix Inc (CMRX) - Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 26.04.2025

Chimerix (CMRX) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:Chimerix Inc. (CMRX)
Barang unggulan chimerix.com

Regular royalties from legacy oncology patents sustain the current operational momentum of Chimerix, Inc. (CMRX) while new drugs undergo clinical trials. This indicator measures the rate of change in quarterly sales, allowing for an assessment of cash flow stability and the risk of business stagnation, which makes the quarterly revenue growth rate a key signal for determining the safety of long-term capital.

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Heron Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRBP (Corbus Pharma)|CRDF: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal beyondspringpharma.com (BYSI)|Wutah pendapatan kuartal marang kuartal bioatla.com|LIXT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CTXR|Wutah pendapatan triwulanan Cellectar Corp (CLRB)|Wutah pendapatan kuartal marang kuartal BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Dinamika pendapatan kuartal marang kuartal|APRE: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal NCNA|Wutah dodolan triwulanan CYCC|Wutah dodolan triwulanan G1 Therapeutics (GTHX)|Wutah pendapatan kuartal marang kuartal Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan kuartal marang kuartal|Oncternal Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)